Myriad Genetics, Inc. (MYGN) Tops Q4 EPS by 2c, FY EPS Guidance Falls Short
Tweet
Share
E-mailGet Alerts MYGN Hot Sheet
Price: $4.54 +3.65%
EPS Growth %: -220.0%
Financial Fact:
Income from continuing operations before income taxes: 4M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -220.0%
Financial Fact:
Income from continuing operations before income taxes: 4M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Myriad Genetics, Inc. (NASDAQ: MYGN) reported Q4 EPS of $0.48, $0.02 better than the analyst estimate of $0.46. Revenue for the quarter came in at $188.8 million versus the consensus estimate of $187.68 million.
Myriad Genetics, Inc. sees FY2015 EPS of $1.90-$2.00, versus the consensus of $2.11. Myriad Genetics, Inc. sees FY2015 revenue of $800-820 million, versus the consensus of $815.6 million.
For earnings history and earnings-related data on Myriad Genetics, Inc. (MYGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- JPMorgan Downgrades Anima Holding SA (ANIM3:BZ) to Neutral
- FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
